Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 10, 2014 - Issue
Submit an article Journal homepage
76
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study

Weiwei Zhu1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China;2 Brain Hospital of Hunan Province, Changsha, People’s Republic of China
,
Zhanchou Zhang1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China
,
Jingfeng Qi1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China
,
Fang Liu3 First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
,
Jindong Chen1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China;4 National Technology Institute of Psychiatry, Changsha, People’s Republic of China;5 Key Laboratory of Psychiatry and Mental Health of Hunan Province, Changsha, People’s Republic of China
,
Jingping Zhao1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China;4 National Technology Institute of Psychiatry, Changsha, People’s Republic of China;5 Key Laboratory of Psychiatry and Mental Health of Hunan Province, Changsha, People’s Republic of China
&
Xiaofeng Guo1 Institute of Mental Health, Second Xiangya Hospital, Central South University, Changsha, People’s Republic of China;4 National Technology Institute of Psychiatry, Changsha, People’s Republic of China;5 Key Laboratory of Psychiatry and Mental Health of Hunan Province, Changsha, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1317-1323 | Published online: 14 Jul 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yu-Chi Huang, Pao-Yen Lin, Yu Lee, Chi-Fa Hung, Su-Ting Hsu, Chih-Ching Wu & Liang-Jen Wang. (2018) Serum levels of β-hydroxybutyrate and pyruvate, metabolic changes and cognitive function in patients with schizophrenia during antipsychotic treatment: a preliminary study. Neuropsychiatric Disease and Treatment 14, pages 799-808.
Read now

Articles from other publishers (3)

Parham Pooladgar, Mehdi Sakhabakhsh, Arsia Taghva & Saeed Soleiman-Meigooni. (2022) Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases. Iranian Journal of Pharmaceutical Research 21:1.
Crossref
Antón L. Martínez, José Brea, Sara Rico, María Teresa de los Frailes & María Isabel Loza. (2021) Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments. International Journal of Molecular Sciences 22:18, pages 9905.
Crossref
Hugo Geerts, Patrick Roberts & Athan Spiros. (2015) Assessing the synergy between cholinomimetics and memantine as augmentation therapy in cognitive impairment in schizophrenia. A virtual human patient trial using quantitative systems pharmacology. Frontiers in Pharmacology 6.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.